Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/06/14 | Current report filing |
|
41 | ||
| 11/06/14 | Current report filing |
|
24 | ||
| 10/14/14 | Current report filing |
|
5 | ||
| 10/10/14 | Current report filing |
|
7 | ||
| 09/24/14 | Annual report to security holders |
|
1 | ||
| 09/18/14 | Current report filing |
|
4 | ||
| 09/17/14 | Definitive proxy statements |
|
66 | ||
| 09/12/14 | Initial statement of beneficial ownership of securities |
|
5 | ||
| 08/14/14 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
62 | |
| 08/13/14 | Current report filing |
|
6 |